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Abstract
Background/Aims: Sustained increases in the circulating concentration of saturated fatty 
acids (SFAs, e.g. palmitate (PA), as seen during obesity, induces a chronic low grade inflam-
matory state that has been linked to metabolic dysfunction in tissues such as skeletal muscle 
that is characterized by disturbances in mitochondrial function and heightened production of 
reactive oxygen species (ROS). In contrast, monounsaturated (MUFAs, e.g. palmitoleate, PO; 
oleate, OL) and certain polyunsaturated (PUFAs, e.g. linoleate, LO) fatty acids have been shown 
to protect against some of the harmful metabolic effects induced by SFAs although it currently 
remains unknown whether this protection is associated with improved morphological and 
functional changes in mitochondrial biology and redox status in skeletal muscle cells. The aim 
of the present study was to investigate this issue. Methods: Rat skeletal (L6) myotubes were 
subject to sustained 16h incubation with SFAs either alone or in combination with a MUFA 
(PO, OL) or PUFA (LO) prior to performing subcellular fractionation, immunoblotting, fixed/
live cell imaging (for assessment of mitochondrial morphology and ROS) or analysis of real 
time mitochondrial respiration. Results: Incubation of L6 myotubes with PA or stearate (SFA, 
C18:0) but not laurate (a medium chain SFA, C12:0) induced a robust increase in proinflamma-
tory NFkB signaling as judged by loss of IkBα and increased expression of IL-6. This height-
ened SFA-induced proinflammatory tone was associated with increased production of ROS 
(superoxide and hydrogen peroxide) and significant loss in proteins involved in mitochon-
drial biogenesis, respiration and morphology (i.e. PGC1α, SDHA, ANT1 and MFN2). Consistent 
with these changes, PA induced profound fragmentation of the mitochondrial network and a 
marked reduction in mitochondrial respiratory capacity. These changes were not evident in 
myotubes incubated with PO, OL or LO alone, and, strikingly, these MUFAs and PUFA not only 
negated the proinflammatory action of PA, but antagonised the biochemical, morphological 
and functional changes in mitochondrial biology and ROS production induced in myotubes 
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by the sustained oversupply of PA. Conclusion: Our findings indicate that PO, OL and LO ex-
hibit anti-inflammatory and antioxidant characteristics and, significantly, they can ameliorate 
SFA-induced disturbances in mitochondrial form and function. These observations may have 
important nutritional implications in developing strategies that could potentially help limit 
obesity-induced metabolic dysfunction in tissues such as skeletal muscle.
Introduction
Increased proinflammatory signalling has been linked with obesity-induced metabolic 
dysfunction and insulin resistance in tissues such as skeletal muscle, and is characterised 
by elevated production of cytokines such as interleukin-6 (IL-6) and tumour necrosis fac-
tor (TNFα) [1, 2]. An important driver of metabolic dysfunction under these circumstances 
is considered to be fatty acids, in particular saturated fatty acids (SFA, e.g. palmitate (PA)), 
whose circulating concentration is characteristically elevated during obesity [3] and which, 
unlike unsaturated fatty acids, have long been known to be less efficiently oxidised [4-6] 
and therefore more obesogenic [7]. Consequently, sustained oversupply of SFAs may result 
in their incomplete oxidation and accumulation as short chain acyl-carnitines [8] and/or 
greater partitioning into lipotoxic fatty acid-derived molecules (e.g. such as ceramide and 
diacylglycerol). Such molecules have been implicated in the induction of a proinflammatory 
response [1, 9-11] as well as impaired signalling downstream of the insulin receptor [12-
15]. The ability of muscle cells to efficiently oxidise fatty acids is crucially dependent upon 
mitochondrial capacity which has been shown in numerous studies to be markedly reduced 
during obesity and diabetes [16-18]. Whether this loss in mitochondrial capacity is a cause 
or consequence of insulin resistance remains a matter of considerable debate [19, 20], but 
there is growing acceptance that insulin resistance induced by the sustained over provision 
of SFAs is closely associated with significant disturbances in mitochondrial energy homeo-
stasis [17]. We have recently shown, for example, that skeletal muscle cells subject to fuel 
overloading with palmitate exhibit a profound increase in mitochondrial fragmentation and 
mitophagy that is accompanied by increased generation of reactive oxygen species (ROS), as 
well as a decline in the expression/abundance of proteins that influence both mitochondrial 
biogenesis and respiration that collectively may help account for the reduced mitochondrial 
respiratory capacity [21]. Significantly, these SFA-induced disturbances in mitochondrial 
morphology and function can be countered by pharmacological or genetic repression of the 
proinflammatory IKKβ-NFkB signalling axis, which also coincides with enhanced cellular 
responsiveness to insulin [21]. Previous studies in cultured skeletal muscle cells have also 
noted that palmitate exhibits a greater propensity to induce mitochondrial DNA (mtDNA) 
damage and that strategies that help mitigate this not only improve mitochondrial redox 
status, but serve to partially restore insulin sensitivity of muscle cells [22]. Such observa-
tions imply that the chronic low-grade inflammatory state that is seen in muscle during obe-
sity may partly be instituted by the rise in circulating SFAs and, as such, may contribute to 
changes in mitochondrial form and function that result in the development and progression 
of insulin resistance in skeletal muscle.
In contrast, mono- or poly-unsaturated fatty acids (MUFAs and PUFAs) do not possess 
the same lipotoxic or pathogenic potential as that ascribed to SFAs and, remarkably, some 
unsaturated fatty acids (e.g. palmitoleate) have been shown to not only promote beneficial 
cellular and systemic effects on metabolic homeostasis [23-25], but also mitigate some of 
the harmful effects associated with SFA oversupply [26-28]. In 3T3-L1 adipocytes, for ex-
ample, sustained exposure of cells to palmitoleate promotes greater mitochondrial energy 
expenditure as demonstrated by increased fatty acid oxidation and ATP synthesis, which is 
likely to be facilitated by the associated increase in the abundance of OXPHOS complexes 
[29]. Similarly, unsaturated fatty acids (palmitoleate, oleate and linoleate) also stimulate 
mitochondrial activity in human skeletal muscle cells; an effect that has been linked to the 
induction of PGC1α key transcriptional coactivator that stimulates mitochondrial biogenesis 
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and energy metabolism [30]. Furthermore, analysis of real time mitochondrial bioenergetics 
indicate that whilst SFAs reduce the coupling efficiency of oxidative phosphorylation in hu-
man myoblasts, unsaturated fatty acids (e.g. oleate) do not, thereby further supporting the 
idea that MUFAs are better tolerated and do not overtly impact on mitochondrial respira-
tory function [31]. In line with this, studies in cultured rat L6 muscle cells have shown that 
although oleate per se has no discernible effect on ROS production or mtDNA its provision 
antagonises the excessive generation of ROS, mtDNA damage and loss of insulin sensitiv-
ity induced by PA and that it may do so by promoting PGC1α expression/abundance, ATP 
levels and cell viability [32]. It is also noteworthy that recent work has shown that the abil-
ity of oleate to suppress production of proinflammatory cytokines via the canonical NFkB 
signalling pathway and mitochondrial superoxide production blunts PA-driven myocellular 
atrophy [33]. This latter observation implies that SFA-induced mitochondrial dysfunction 
may be a contributing factor in muscle atrophy and that MUFAs may have therapeutic value 
in restraining loss of muscle mass during conditions such as obesity and ageing by helping 
to preserve myocellular mitochondrial health [33]. In addition to stimulating mitochondrial 
activity, unsaturated fatty acids can also promote synthesis of neutral triglyceride (TAG) in 
myotubes [34, 35] and may also function as mild mitochondrial uncouplers [36]. These met-
abolic responses allow greater oxidation and/or partitioning of SFAs into an inert molecular 
species that may help off-set their availability for synthesis of lipotoxic fatty acid-derived 
intermediates. Precisely how MUFAs and PUFAs convey such benefits and how they might 
antagonise SFA-induced disturbances in metabolic function are not fully understood but we 
hypothesise that their anti-inflammatory action helps counter the deleterious impact that 
SFAs have upon mitochondrial form, respiratory function and ROS generation. The purpose 
of the studies reported herein was to test this hypothesis. In this study, we present novel data 
showing the differential impact that SFAs and unsaturated fatty acids have on mitochondrial 
morphology and bioenergetics and show that the capacity of MUFAs and PUFAs to amelio-
rate PA-induced mitochondrial dysfunction is associated with a suppression in proinflam-
matory signalling, ROS production but not a reduction in PA uptake.
Materials and Methods
Chemicals and reagents
Tisssue culture media (α-MEM, α-minimum essential medium) and serum (foetal bovine), Mitosox, 
prolong diamond antifade mountant, mitotracker dyes were all purchased from Thermo Fisher Scientific 
(UK). MitoSpy™ Green FM was from BioLegends (UK). MitoPYI, hepatocyte growth factor, laurate (C12:0), 
palmitate (C16:0), stearate (C18:0), palmitoleate (C16:1), oleate (C18:1), linoleate (C18:2), oligomycin, 
FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone), rotenone, antimycin-A, hygromycin B, hu-
man, SYBR® Green JumpStart Taq Ready Mix were all purchased from Sigma Aldrich, UK). [3H]-palmitic 
acid was obtained from PerkinElmer Life Sciences.
L6 skeletal muscle cell culture and fatty acid treatment
L6 muscle cells were cultured in a-minimal essential media (aMEM) containing 2% (v/v) foetal bovine 
serum (FBS) and 1% (v/v) antibiotic/antimycotic solution (100 units/ml penicillin, 100 mg/ml streptomy-
cin, 250 ng/ml amphotericin B) in a humidified atmosphere of 95% air and 5% CO2 at 37°C and allowed to 
differentiate into myotubes as previously described in serum-containing media with glucose (5 mM) [37]. 
For fatty acid treatments a 100 mM stock solution of the appropriate fatty acid was prepared in absolute 
ethanol as previously reported [38, 39]. This stock was subsequently diluted to a final concentration as 
indicated in the figure legends by addition to culture media containing 2% (w/v) fatty acid free BSA and al-
lowed to precomplex for 1h at 37°C before being applied onto myotubes. Based on previous work from our 
group assessing dose- and time-dependent responses of palmitate that induced maximally effective changes 
in proinflammatory NFkB signalling, ROS generation and insulin signalling [21, 34] (also see Supplementary 
Fig. S1 and S2 – for all supplementary material see www.cellphysiolbiochem.com), myotubes were incu-
bated with 0.4 mM palmitate for 16h in the absence and presence of unsaturated fatty acids (palmitoleate 
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(PO, C16:1), Oleate (OL, C18:1) or linoleate (LO, C18:2)) at concentrations and for periods indicated in the 
figure legends. Given that muscle cells in the current studies were used as fully differentiated myotubes, it 
worth stating that treatment with palmitate and unsaturated fatty acids at the concentration and incubation 
period indicated did not adversely affect myotube viability as judged by analysis of total cell protein to DNA 
content (Supplementary Fig. S2C).
Quantitative real time PCR, mitochondrial DNA quantification and mitochondrial isolation
Following appropriate treatments with fatty acids and/or fluorescent dyes as indicated in the figure 
legends, L6 myotubes were prepared for RNA extraction and qPCR analysis as described previously [21]. 
In brief, the TRizol method (Thermo Fisher Scientific, UK) was used to isolate total RNA from myotubes 
from which cDNA was prepared using a qScript cDNA synthesis kit as per manufacturer’s instructions 
and real time PCR Syber Green method subsequently used to quantify IL-6 and actin mRNA using the fol-
lowing qPCR primer sequences: IL-6, forward 5’ AGCCACTGCCTTCCCTACTT 3’ and reverse 5’ GCCATTG-
CACAACTCTTTTCTC 3’; Actin, forward 5’ TGGAGAAGATTTGGCACCACAC 3’ and reverse 5’ CAGAGGCATA-
CAGGGACAACAC 3’. The abundance of mitochondrial DNA (mtDNA) was used as a proxy for mitochondrial 
mass. Total DNA was extracted from L6 myotubes using a Qiagen DNaesy kit and mtDNA quantified using 
qPCR primers directed against the mitochondrial ND4 gene (Forward 5’ GAGGCAACCAAACAGAACGC 3’ and 
Reverse 5’ ATCATGTTGAGGGTAGGGGGT 3’) and the nuclear-encoded COX4 gene (Forward 5’ AATGTTGGC-
TACCAGGGCAC 3’ and Reverse 5’ GGGTAGTCACGCCGATCAAC 3’) using the Syber Green method. Data was 
expressed as a ratio of the ∆∆Ct ND4 to the ∆∆Ct of COX4. For analysis of mitochondrial proteins, a mito-
chondria isolation kit (#89874, Thermo Fisher Scientific) was used to prepare a mitochondrial enriched 
membrane fraction from L6 myotubes as per manufacturer’s instructions.
SDS-PAGE and immunoblotting
Cell lysates, cytosolic or mitochondrial enriched fractions (20 µg protein) from muscle cells were sub-
jected to SDS/PAGE on 10% resolving gels and transferred onto polyvinylidene difluoride (PVDF) mem-
branes (Millipore, Harts, UK), as described previously [37]. Membranes were immunoblotted with the fol-
lowing antibodies: actin (#A5060) and tubulin (#T6074) were obtained from Sigma; ANT-1 (#ab180715), 
IkBα (#SC-371), SDHA (#SC98253) and GAPDH (#SC32233) were purchased Santa Cruz; TOM20 (#42406S), 
COX4 (#4580S), Catalase (#14097) and SOD2 (#D9V9C) were all purchased from Cell Signalling Technol-
ogy; UCP3 (#GTX112699) from Genetex; TFAM (ab131607), NRF1 (#ab175932), NRF2 (#ab92946) and 
PGC1α (#ab54481) were from Abcam. Primary antibody detection was performed using appropriate horse-
radish peroxidase (HRP) conjugated secondary mouse (#7076S) or rabbit (#7074S) antibodies were pur-
chased from Cell Signalling Technology and visualized using enhanced chemiluminescence (Pierce-Perbio 
Biotech, Tattenhall, UK) on Kodak X-OMAT film (Eastman-Kodak, Rochester, UK) or digital images acquired 
using the LICOR system. Immunoreactive protein bands were quantified using ImageJ Software.
Analysis of Reactive Oxygen Species (ROS)
Fluorescence probes were used for detection and quantification of ROS. For analysis of superoxide, 
L6 myotubes were subject to experimental treatments as indicated in the figure legends prior to a 30 min 
incubation with 5 µM MitoSox in a humidified atmosphere of 95% air and 5% CO2 at 37°C. Mitosox is specifi-
cally targeted to mitochondria in live cells and its oxidation by superoxide produces red fluorescence that 
was quantified using a CLARIOstar plate reader with absorption/emission maxima at 510/585 nm as per 
instructions from the manufacturer (ThermoFisher Scientific).
For analysis of hydrogen peroxide (H2O2), muscle cells were incubated with 5 µM MitoPYI (a mitochon-
drial targeted H2O2 probe) and 1 µM deep red cell tracker in a 37°C incubator with a humidified atmosphere 
of 95% air and 5% CO2 for 45 min. Myotubes were subsequently imaged using a Zeiss confocal microscope 
with excitation/emission maxima for MitoPYI set to 488/530 nm and that for the cell tracker at 633/647 
nm. Microscope images were analysed to quantify fluorescence generated by MitoPYI from at least 8-10 
random visual fields (40-50 myotubes) per condition per experiment using ImageJ software.
Analysis of cellular respiration and mitochondrial energetics
A Seahorse XF24 analyser was used to analyse respiration by measurement of oxygen consumption 
rates (OCR) in L6 myotubes. Muscle cells were cultured on Seahorse culture plates in serum-containing 
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media supplemented with 5 mM D-glucose and/or fatty acids at concentrations indicated in the figure leg-
ends for 16 h prior to analyses of basal, ATP-Linked and maximal respiration and non-mitochondrial oxygen 
consumption achieved by the addition of oligomycin (1 μM), FCCP (carbonyl cyanide 4-(trifluoromethoxy)
phenylhydrazone) (2 μM), rotenone (1 μM) and Antimycin (2 μM) at times indicated on the OCR traces. 
Mitochondrial respiration rates were normalised to cell protein within the culture wells of the Seahorse 
plate [21].
Palmitate uptake in L6 myotubes
Fatty acid uptake was assayed in L6 myotubes as described previously [23, 34]. Myotubes were cul-
tured in twelve-well dishes and incubated with 0.4mM [3H]-palmitic acid (1µCi/mL) in the absence and 
presence of 0.4mM oleate for periods up to 2 h as indicated in the figure and legend. At the specified time 
periods uptake was terminated by rapid aspiration of uptake buffer and myotubes washed twice with ice-
cold 0.9% (w/v) NaCl prior to lysis with 50mM NaOH. Radioactivity in muscle cell lysates was subsequently 
quantified by liquid scintillation counting.
Analysis of mitochondrial morphology
Mitospy Green (BioLegend, UK) FM was used to investigate effects of fatty acid treatments upon mi-
tochondrial morphology using fixed or live cell imaging as previously described [21]. Briefly, L6 myotubes 
were grown on glass coverslips (15 mm2) prior to incubation with fatty acids for times and at concentrations 
indicated in the figure legends. At the end of such treatments, myotubes were washed and subsequently 
maintained in fresh media containing 300 nM Mitospy for 30 min at 37°C in a 95% O2/5% CO2 environment. 
After treatment with Mitospy, cells were washed and subsequently fixed with 2% (w/v) paraformaldehyde 
and mounted in prolonged diamond antifade before being visualised using a Zeiss confocal microscope. 
For some experiments, myotubes were grown on 8 well chamber slide plates (Ibidia, UK) and following 
appropriate treatment with fatty acids were washed with fresh phenol red free media prior to incubation 
with Mitospy. Live cell imaging of mitochondrial morphology was then performed using Zeiss confocal mi-
croscope at 37°C in a 5% CO2 chamber with excitation/emission set at 480nm and 520nm. ZEISS ZEN mi-
croscope software or ImageJ was then used to quantify mitochondrial length. To reduce potential bias, at 
least 50 myotubes were analysed within 10 randomly chosen fields for each experimental condition tested. 
Mitochondrial morphology within myotubes was categorised as either tubular/elongated (including as part 
of a network) when mitochondrial length was greater than 1 µm or spheroid/fragmented if mitochondria 
were 1 µm or less in length. The proportion of mitochondria falling into each category was then expressed 
as a percentage.
Statistical analysis
Where appropriate, details of the number of experimental replicates within a single experiment and 
the number of times each experiment was performed are detailed in the individual figure legends. Statisti-
cal analysis was performed using GraphPad Prism version 7 software using one-way analysis of variance 
(ANOVA) and Tukey post hoc test for multiple comparisons. Values were considered significant at P < 0.05.
Results
Saturated fatty acids induce proinflammatory NFkB signalling and mitochondrial dys-
function in a chain length dependent manner
We have recently shown that myotubes subjected to a sustained period of exposure to 
0.4 mM palmitate (PA), a C16:0 SFA, exhibit heightened NFkB proinflammatory signalling, 
which is mechanistically linked to increased mitochondrial fragmentation and impaired mi-
tochondrial respiratory function [21]. What is not known is whether this SFA-induced mito-
chondrial dysfunction is chain length dependent and whether it is also a feature associated 
with myotube exposure to unsaturated fatty acids. Fig. 1A shows that myotubes exposed to 
0.4 mM PA or stearate (ST, a C18:0 SFA) for 16 h in media also containing 5 mM D-glucose 
exhibit increased NFkB activation as judged by the loss of IkBα and elevated expression of 
IL-6, an NFkB gene target. Strikingly, this increased proinflammatory drive was not observed 
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in myotubes incubated with an equivalent concentration of laurate (LA), a medium chain 
(C12:0) SFA (Fig. 1A). Furthermore, the activation of the NFkB pathway by PA and ST was 
associated with a profound change in mitochondrial morphology that was visualised by live 
cell imaging in which mitochondria were stained using Mitotracker Green. The dye accu-
mulates within mitochondria but does not penetrate nuclei, which, consequently, become 
highlighted by virtue of dye exclusion. Fig. 1B and 1C show that myotubes not subjected to 
any prior fatty acid treatment exhibit mitochondria that are predominantly (~80%) organ-
ised as part of an elongated/tubular network (in which mitochondrial length was equal to 
or greater than 1 um as determined using ImageJ software), whereas they become highly 
fragmented and spheroid in nature (~70%) upon myotube treatment with PA and, more 
Fig. 1. Effects of fatty acyl chain saturation on NFkB signalling, mitochondrial morphology and cellular 
respiration in L6 myotubes. L6 myotubes were incubated in media containing D-glucose (5 mM) in the ab-
sence and presence of saturated fatty acids laurate (LA, C12:0), palmitate (PA, C16:0) or stearate (ST, C18:0) 
for 16 h prior to analysis of: (A) cellular IkBα abundance by immunoblotting and IL6 and β-actin mRNA 
abundance by qPCR; (B) analysis and quantification of mitochondrial morphology assessed by mitotracker 
green (mitospy) staining and confocal microscopy. The white boxed areas are magnified to show differ-
ences in morphology, the scale bar in the main visual fields represents 5 μm. (C) Mitochondrial morphology 
(elongated versus fragmented) was subsequently quantified using ImageJ software. For analysis of real-time 
cellular respiration in L6 myotubes we used a Seahorse XF24 analyser. L6 myotubes were incubated for 
16 h with either GLC (5 mM) alone (control) or glucose co-supplemented with 0.4 mM of either LA, PA or 
ST. Oligomycin (1 μM), FCCP (1 μM) and a rotenone (1 μM)/antimycin-A (2 μM) mix were added at times 
indicated by the dotted lines on the Seahorse trace. The trace shown in (D) is a representative readout 
of oxygen consumption rate (OCR) from a single experiment with time point (mean ± SD) representing a 
triplicate measurement. The data shown in (E) indicates the respiratory capacity ratio, coupling efficiency 
of oxidative phosphorylation and ATP linked respiration respectively (5 determinations/condition/experi-
ment).  The graphical data shown in (A, C and E) are the combined analyses of three separate experiments 
and represent mean ± SEM. Asterisks indicate a significant change (P<0.05) to the control condition or 
between the indicated bars.
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so (~80%) when incubated with ST (Fig. 1C). In contrast, such fragmentation was not appar-
ent in myotubes that had been incubated with LA. Consistent with the idea that a fragmented 
mitochondrial morphology may be associated with reduced bioenergetic efficiency, analysis 
of mitochondrial respiration revealed that both PA and ST significantly reduced the cellular 
oxygen consumption rate (OCR) and that this was associated with a decline in respiratory 
capacity, coupling efficiency and ATP-linked respiration within myotubes (Fig. 1D and 1E). 
In contrast, LA, which did not induce any notable changes in proinflammatory NFkB signal-
ling or mitochondrial fragmentation, did not impact significantly on these bioenergetic para-
meters (Fig. 1D and 1E).
Effects of Mono- and poly-unsaturated fatty acids on PA-induced proinflammatory signal-
ling, PA uptake, mitochondrial morphology and respiration
Unlike PA, sustained (16 h) incubation of L6 myotubes with MUFAs, palmitoleate (PO, 
C16:1) and oleate (OL, C18:1), or the PUFA, linoleate (LO, C18:2), did not induce an increase 
in NFkB signalling based on analysis of IkBα abundance and IL6 gene expression as readout 
(compare lanes 6-8 with lane 2, Fig. 2A and 2B). Significantly, however, all three fatty acids 
were found to repress the proinflammatory drive observed with over-supply of PA (compare 
lanes 3-5 with lane 2, Fig. 2A and 2B, and Supplementary Fig. S1). It is plausible that unsatu-
rated fatty acids may restrain the proinflammatory action of PA by competitively inhibiting 
its uptake via a common cell surface fatty acid transporter. To test this possibility, we assayed 
uptake of radiolabelled PA in the absence and presence of a competing concentration of OL. 
Fig. 2C shows that we observed a time-dependent increase in PA uptake by myotubes that, 
strikingly, was further augmented in the presence of 0.4 mM OL thus negating the idea that 
OL restrains the proinflammatory effect of PA by suppressing its uptake.
Given that SFA-induced proinflammatory signalling is associated with disturbances 
in mitochondrial form and function [21], we subsequently performed live cell imaging of 
myotubes stained with Mitotracker Green to assess the effects of MUFA/PUFA provision on 
Fig. 2. Effect of unsaturated fatty acids on palmitate induced NFkB proinflammatory signalling and palmi-
tate uptake. L6 myotubes were incubated for 16 h in media containing D-glucose (5 mM) supplemented with 
or without palmitate (PA, 0.4 mM) or unsaturated fatty acids palmitoleate (PO, C16:1), Oleate (OL, C18:1) 
or linoleate (LO, C18:2) at 0.4 mM as indicated prior to analysis of (A) cellular IkBα abundance by immuno-
blotting and (B) IL6 and β-actin mRNA abundance by qPCR. The data represent the combined analyses of 
four separate experiments. For PA uptake (C), myotubes were incubated in uptake buffer containing 0.4 mM 
PA and [3H]-PA (1 mCi/ml) palmitate in the absence and presence of 0.4 mM OL for times indicated.  Data 
in panels A and B are from three separate immunoblotting/qPCR experiments, whereas the uptake data is 
from six separate experimental determinations.  Data is presented as mean ± SEM. Asterisks indicate a sig-
nificant change (P<0.05) to the control condition (lacking any fatty acid additions) or between the indicated 
bar values.
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mitochondrial morphology. Consistent with recent work from our lab [21] and the data pre-
sented in Fig. 1B, PA induced a marked increase in mitochondrial fragmentation that was 
not apparent in myotubes incubated with PO, OL or LO alone in which mitochondria were 
predominantly (70-80%) tubular/elongated in form (Fig. 3A and 3B). Strikingly, the increase 
in mitochondrial fragmentation induced by PA was significantly blunted upon co-exposure 
of myotubes with either PO, OL or LO. We have previously reported that the PA-induced 
fragmentation of the mitochondrial network is notably associated with a cellular reduction 
in mitofusin-2 (MFN2) content, an outer mitochondrial membrane GTPase that critically 
helps support mitochondrial fusion [21]. Analysis of MFN2 abundance in a mitochondrial-
enriched membrane fraction showed that relative to untreated myotubes those incubated 
Fig. 3. Effect of palmitate and/or unsaturated fatty acids on mitochondrial morphology. L6 myotubes were 
incubated for 16 h in media containing D-glucose (5 mM) supplemented with or without palmitate (PA, 0.4 
mM) or unsaturated fatty acids palmitoleate (PO, C16:1), Oleate (OL, C18:1) or linoleate (LO, C18:2) at 0.4 
mM as indicated prior to: (A) mitotracker green (mitospy) staining and live cell imaging by confocal micros-
copy of L6 myotubes (the scale bar represents 5 μm); (B) analysis of mitochondrial morphology (elongated 
versus fragmented) was quantified using ImageJ software and presented as elongated/tubular if mitochon-
dria were >1 μm or fragmented if <1 μm in length and (C) Immunoblotting and quantification of mitofusin 2 
(MFN2), a key regulator of mitochondria dynamics in a mitochondrial-enriched fraction. The abundance of 
TOM20 a mitochondrial marker protein was used as a gel loading control.  The bar graph represents quanti-
tative analysis of MFN2 abundance relative to TOM20 with data presented as mean + SEM from a minimum 
of 4 separate experiments. The asterisk indicates a significant change (P<0.05) to the control condition 
(lacking any fatty acid additions).
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with PA exhibit ~50% loss in MFN2, but this was averted upon co-treatment of myotubes 
with MUFAs or PUFA (Fig. 3C).
Given that morphological changes in mitochondrial form caused by PA oversupply could 
be restrained by co-provision of PO, OL and LO we subsequently tested whether these fatty 
acids could also mitigate disturbances in mitochondrial respiration induced by PA in myo-
tubes. Fig. 4A depicts a real time OCR trace from a single experiment in which each time point 
represents data from a triplicate measure. The trace shows that whilst sustained preincuba-
tion of myotubes with 0.4 mM PA treatment suppresses the OCR, incubating myotubes with 
equivalent concentrations of PO, OL or LO did not cause any significant deviation in OCR 
from that assayed in untreated myotubes. Significantly, all three unsaturated fatty acids an-
tagonised the PA-induced reduction in basal and ATP-linked respiration and partially ame-
liorated the loss in maximal respiratory capacity (Fig. 4B). The reduced respiratory capacity 
seen in myotubes in response to PA oversupply could not be accounted for by a reduction in 
mitochondrial mass given that we observed no significant change in mitochondrial DNA in 
response to treatment with any of the fatty acids we used (Fig. 4C).
Fig. 4. Effect of palmitate and/or unsaturated fatty acids on mitochondrial respiratory function. L6 myo-
tubes were incubated for 16 h in media containing D-glucose (5 mM) supplemented with or without palmi-
tate (PA, 0.4 mM) or unsaturated fatty acids palmitoleate (PO, C16:1), Oleate (OL, C18:1) or linoleate (LO, 
C18:2) at 0.4 mM as indicated prior to analysis of real-time cellular respiration using a Seahorse XF24 ana-
lyser. Oligomycin (1 μM), FCCP (1 μM) and a rotenone (1 μM)/antimycin-A (2 μM) mix were added at times 
indicated by the dotted lines. (A) shows a representative readout of oxygen consumption rate (OCR) from 
a single experiment with each data point representing the mean ± SD of a triplicate measurement. (B) The 
graphical data shows basal respiration, ATP-linked respiration and maximal respiration (OCR after FCCP 
stimulation). (C) Mitochondrial DNA quantification by qPCR. Data in (B) and (C) are mean ± SEM from 5 and 
3 independent experiments, respectively. The asterisk indicates a significant change (P<0.05) to the control 
condition (lacking any fatty acid additions).
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Mono- and poly-unsaturated fatty acids prevent the loss of mitochondrial proteins induced 
by palmitate
In myotubes, PA has been shown to induce deleterious changes in the abundance of 
proteins linked to regulation of mitochondrial biogenesis and respiratory function and these 
changes can be countered by inhibiting the associated increase in proinflammatory NFkB 
signalling caused by the SFA [21]. Since MUFAs and PUFAs can repress PA-induced NFkB 
signalling (Fig. 2, [34]) we subsequently assessed whether the ability of PO, OL and LO to 
restrain PA-induced disturbances in respiratory function involved mitigating changes in pro-
teins that impact mitochondrial biology. Fig. 5 shows that PA caused a significant decline in 
PGC1α, a transcriptional coactivator that plays a key role in regulating mitochondrial biogen-
esis and function, as well that of succinate dehydrogenase (SDHA), mitochondrial ADP-ATP 
translocase (ANT1) and uncoupling protein 3 (UCP3) that all have crucial roles in OXPHOS. 
In addition, the abundance of NRF1, which has been linked to the transcriptional control of 
numerous genes involved in mitochondrial function was reduced by ~70%, whereas that of 
NRF2, a protein involved in regulating oxidative stress-induced gene expression was only 
modestly affected by PA but whose abundance was elevated in myotubes incubated with PO, 
OL or LO. Fig. 5 also shows that the abundance of two key anti-oxidant enzymes, MnSOD2 
and catalase, were elevated in myotubes by PA, but, consistent with our recent work [21], PA 
did not induce any notable changes in COX4.1 or TFAM, a component of the mitochondrial 
transcription initiation complex. Notably, however, the changes induced in the protein abun-
dance of PGC1α, SDHA, ANT1, UCP3, NRF1, MnSOD2 and catalase by PA oversupply were 
antagonised in myotubes that were co-incubated with PO, OL and LO.
Fig. 5. Effect of palmitate and/or unsaturated fatty acids on the abundance of proteins implicated in the 
regulation of mitochondrial function. L6 myotubes were incubated for 16 h in media containing D-glucose 
(5 mM) supplemented with or without palmitate (PA, 0.4 mM) or unsaturated fatty acids palmitoleate (PO, 
C16:1), Oleate (OL, C18:1) or linoleate (LO, C18:2) at 0.4 mM as indicated prior to cell lysis and (A) immuno-
blot and (B) quantitative analysis of PGC1α, SDHA, COX4.1, ANT1, TFAM, NRF1, NRF2, UCP3, Catalase, and 
MnSOD2. Data in (B) are presented as mean ± SEM from three or four separate experiments (one sample/
condition/experiment). The asterisk indicates a significant change (P<0.05) to the control condition (lack-
ing any fatty acid additions) or between the indicated bars.
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Effects of fatty acid provision on mitochondrial ROS generation and mitochondrial mem-
brane potential
Mitochondrial respiration represents a primary site of ROS generation because of oxy-
gen being reduced by electrons “leaking” out from within the ETC. ROS generation is elevat-
ed in skeletal muscle cells under conditions when supply of respiratory fuel exceeds cellular 
energy demand [21] and, as such, this has been linked to increased mitochondrial fragmen-
tation and mitochondrial depolarisation [21, 40]. We consequently sought to address the 
impact of fatty acid provision on ROS and mitochondrial membrane potential within L6 myo-
tubes. For analysis of superoxide we utilised MitoSox, a fluorogenic probe whose targeted 
accumulation and oxidation by superoxide in mitochondria generates red fluorescence that 
can be visualised by live cell imaging. Fig. 6A shows that myotubes treated with 0.4 mM PA 
for 16 h exhibit a 2-fold increase in superoxide, which was countered by co-incubating myo-
tubes with PO, OL and LO in a dose-dependent manner. Of these fatty acids, PO was the most 
potent in suppressing PA-induced superoxide generation although none, by themselves, in-
voked any significant change in superoxide content in myotubes. For analysis of hydrogen 
Fig. 6. Effect of palmitate and/or unsaturated fatty acids on mitochondrial ROS production. L6 myotubes 
were incubated for 16 h in media containing D-glucose (5 mM) supplemented with or without palmitate (PA, 
0.4 mM) or unsaturated fatty acids palmitoleate (PO, C16:1), Oleate (OL, C18:1) or linoleate (LO, C18:2) at 
the concentrations indicated prior to analysis of (A) superoxide production (five measurements/condition/
experiment); (B and C) H2O2 production and (D) mitochondrial membrane potential using spectral analysis 
to monitor JC-10 aggregate: monomer content. Data are presented as mean + SEM from a minimum of four 
separate experiments. The asterisk indicates a significant change (P<0.05) to the control condition (lacking 
any fatty acid additions) or between the indicated bars.
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peroxide (H2O2) under live cell conditions, L6 myotubes were incubated with MitoPYI (a mi-
tochondrial specific florescent H2O2 probe). Fig. 6B depicts representative live cell images of 
myotubes incubated in the absence or presence of PA revealing heightened MitoPYI fluores-
cence in PA-treated myotubes that were costained blue with Cell Tracker dye. Quantification 
of MitoPYI fluorescence indicated that this PA-induced increase in mitochondrial H2O2 was 
~40% and was blunted in myotubes upon coincubation with PO, OL or LO (Fig. 6C). Again, 
these fatty acids alone had no discernible effect on H2O2 content in myotubes.
Mitochondrial membrane depolarization is associated with increased ROS production 
and serves as an indicator of mitochondrial dysfunction. In separate experiments we moni-
tored the effects of SFA, MUFA and PUFA provision to myotubes on the aggregate to mono-
mer ratio of a potentiometric fluorescent dye, JC10, as readout of mitochondrial potential. In 
healthy cells, JC10 accumulates within mitochondria and forms red fluorescent aggregates, 
whereas depolarised mitochondria allow the dye to leak out in its monomeric form and stain 
cells green. Fig. 6D shows that whilst a sustained 16h incubation of myotubes with 0.4 mM 
PO or LO induced a modest reduction in the JC10 aggregate/monomer ratio relative to un-
treated cells, PA has a much more pronounced effect causing a greater depolarisation of the 
mitochondrial membrane potential. This PA-induced mitochondrial depolarisation was par-
tially mitigated in myotubes that had been coincubated with PO and LO.
Discussion
Recent work from our group has demonstrated that the proinflammatory drive that is 
instituted in skeletal muscle cells in response sustained over supply of SFAs, such as PA, is 
mechanistically linked to increases in mitochondrial redox stress and disturbances in mito-
chondrial form and function [21]. In the current study we show that these fatty acid-induced 
changes in mitochondrial biology are not evident when myotubes are incubated with equiva-
lent concentrations of laurate (LA), a medium chain (C12:0) SFA, or when treated with long 
chain mono- and poly-unsaturated fatty acids (PO, C16:1; OL, C18:1; LO, C18:2). Strikingly, 
unlike PA or stearate (another long chain (C18:0) SFA), we show that PO, OL and LO do not 
promote an increase in proinflammatory NFkB signalling and, significantly, that they not 
only antagonise the proinflammatory action of PA, but also mitigate the pathogenic shift in 
mitochondrial morphology, bioenergetics and redox status induced by this SFA.
Previous studies have shown that the increase in proinflammatory NFkB signalling as-
sociated with oversupply of PA may be linked with its ability to engage with and activate 
toll-like receptors [41] or via intracellular stimulation of kinases such as PKCΘ [26], JNK and 
ERK [9] that act as upstream activators of the IKK-NFkB axis. While activation of NFkB sig-
nalling in this context stimulates expression of genes encoding proinflammatory cytokines 
(e.g. IL-6 and TNFα) that may contribute to development of insulin resistance [42], there is 
also increasing recognition that heightened NFkB activation represses expression of genes 
with important roles in mitochondrial biology such as the transcriptional coactivator, PGC1α 
[43] and the ADP/ATP translocase, ANT1 [44]. Repression of the former would affect ex-
pression of PGC1α target genes such as NRF1 and NRF2 [45, 46] that, in turn, will impact 
negatively upon expression of their gene targets including UCP3 and respiratory proteins 
such as SDHA [47, 48], whereas repression of the latter would compromise production and 
transfer of mitochondrial ATP to the cytoplasm [44]. Consistent with these molecular links, 
our data indicate that PA induces a reduction in the protein abundance of PGC1α, ANT1, 
NRF1, UCP3 and SDHA that notably are associated with a significant decline in mitochon-
drial respiratory function. We have previously shown that the PA-induced loss of these pro-
teins and the associated reduction in respiratory capacity can be blunted upon inhibition 
of NFkB-signalling in muscle cells [21] and, as illustrated here, also when myotubes were 
coincubated with either PO and OL (MUFAs) or LO (a PUFA). We contest that the ability of 
these fatty acids to restrain PA-induced mitochondrial dysfunction is most likely linked to 
their anti-inflammatory action as judged by their capacity to repress IkBα loss and IL6 gene 
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expression by PA. Precisely how they antagonise PA-induced NFkB signalling remains poorly 
resolved, but previous work has suggested that MUFAs (PO and OL) not only induce greater 
partitioning of PA into neutral triglyceride but stimulate mitochondrial fatty acid oxidation 
[26, 34] and that, by doing so, this may reduce its channelling into fatty acid derivatives such 
as DAG and ceramides that can induce NFkB signalling via activation of stress kinases [9, 26]. 
The ability of OL to increase fatty acid oxidation has been linked to activation of the cAMP/
protein kinase A (PKA) pathway, which stimulates the SIRT1-PGC1α transcriptional complex 
to upregulate genes supporting fatty acid oxidation in myotubes [49]. The notion that this 
increase in fatty acid oxidation then helps off-set the proinflammatory potential of PA, and 
by extension its capacity to promote mitochondrial dysfunction, is supported by data show-
ing that if uptake and oxidation of fatty acids by mitochondria is suppressed using etomoxir 
then the ability of OL and PO to restrain PA-induced NFkB signalling is markedly reduced 
in C2C12 and L6 myotubes [26, 34]. Furthermore, inhibition of PKA not only attenuates the 
OL-induced increase in fatty acid oxidation but curtails the capacity of this MUFA to rescue 
PGC1α loss in PA-treated myotubes, which is widely regarded as being important for main-
taining mitochondrial homeostasis [26, 49].
A key observation in the present study was the differential effect that acyl chain length 
and saturation have upon mitochondrial morphology. In terminally differentiated L6 myo-
tubes that have not been subjected to fatty acid treatments the mitochondrial network is 
predominantly (~80%) elongated/tubular in nature, which is considered more “healthy” 
and “efficient” than that seen in myotubes treated with PA in which mitochondria are pri-
marily small rounded punctate structures. This shift to a more fragmented morphology was 
not seen in myotubes treated with LA (C12:0), PO, OL or LO, but, compared to PA, was further 
exacerbated in L6 myotubes incubated with stearate (C18:0) suggesting that saturation and 
increased acyl chain length are important fatty acid characteristics driving mitochondrial 
fragmentation that, interestingly, also correlate with their capacity to activate proinflamma-
tory NFkB signalling. Mitochondrial morphology is critically dependent on the relative ex-
pression/activity of proteins that on the one hand support mitochondrial fusion (mitofusins 
(MFN1 and 2) and Opa1) and on the other those promoting mitochondrial fission (Drp1 and 
Fis1). We could not detect any meaningful changes in the total myocellular abundance of 
Opa1 or Drp1 in L6 myotubes in response to PA overloading (data not shown) but did ob-
serve a significant reduction in MFN2. MFN2 expression has been shown to be rapidly down-
regulated in vivo in response to high fat feeding and its expression is also reduced by pro-
inflammatory cytokines, lipid availability, and glucocorticoids [50, 51]. In skeletal muscle, 
PGC1α has been shown to stimulate expression of the Mfn2 gene promoter [52] and given 
that PA represses PGC1α in our myotubes this may help account for the observed reduction 
in MFN2. Consistent with the ability of PO, OL and LO to restrain PGC1α loss in PA-treated 
myotubes, these fatty acids also antagonise the PA-induced loss of MFN2, which may then 
help facilitate retention of an elongated/tubular mitochondrial network that also exhibits 
greater respiratory competency. It is, however, noteworthy that similar studies in C2C12 my-
oblasts in which PA also induces mitochondrial fragmentation did not report any change in 
MFN2 abundance but did observe increases in both Drp1 and Fis1 [53]. The reasons for this 
discrepancy are unclear but may reflect differences that are either cell-type (murine C2C12 
versus rat L6) and/or differentiation (myoblast versus myotube) dependent. In any event, 
the PA-induced loss of MFN2 in L6 myotubes or the increase in Drp1/Fis1 in C2C12 myo-
blasts would result in a dynamic shift towards greater mitochondrial fission that correlates 
with reduced mitochondrial respiratory capacity in both experimental systems.
Increased oxidative stress is also an important regulator of mitochondrial morphology 
and has been shown to induce recruitment of Drp1 to mitochondria where it initiates mito-
chondrial fragmentation that, importantly, can be restrained by ROS scavenging molecules 
[54]. While we see no overall change in cellular Drp1 content in PA-treated myotubes we 
have previously noted that PA induces a modest increase in mitochondrial associated Drp1 
when there is backdrop of heightened mitochondrial ROS production [21]. Under these cir-
cumstances, fragmentation of the mitochondrial network caused by PA can be halted by Mi-
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totempo, a mitochondrial targeted anti-oxidant, thus further underscoring the crucial role 
that ROS play in regulating mitochondrial dynamics [21]. The current findings extend on 
these observations by demonstrating that whilst PA induces a significant increase in both 
mitochondrial superoxide and hydrogen peroxide this increase is not evident in myotubes 
treated with PO, OL or LO and, significantly, that these fatty acids blunt PA driven ROS gen-
eration. This anti-oxidant effect is not unprecedented as studies in C2C12 myotubes examin-
ing the tight coupling between a rise in mitochondrial ROS and muscle atrophy have shown 
that OL not only antagonises ROS production, but negates the expression of genes involved 
in muscle atrophy (e.g. myostatin and atrogin1) and the decline in myotube width that are 
induced by chronic PA treatment [33]. Precisely how availability of OL modifies myotube 
redox status under these circumstances is unclear but it may be linked to regulation of Nrf2, 
a key transcription factor involved in mediating anti-oxidant responses via modulation of 
NADPH:quinone oxidoreductase 1 and Glutathione S-Transferase gene expression [55, 56]. 
Our data indicate that PO, OL and LO all elevate the abundance of this transcription factor 
relative to that seen in myotubes chronically treated with PA which, by contrast, exhibit a 
modest reduction in Nrf2. Previous studies could not demonstrate any OL-dependent in-
crease in Nrf2 gene expression in PA-treated myotubes [33] thus potentially raising the pos-
sibility that the increase in Nrf2 we see following treatment with our test MUFAs and PUFA 
might be linked to increased protein stability, possibly by inhibiting its normal degradation 
via the ubiquitin proteasome pathway [57]. Whether Nrf2 is stabilised by such a mechanism 
and contributes to the antioxidant response of PO, OL and LO is currently unknown but test-
ing this possibility may prove instructive in understanding the differential effect that satu-
rated and unsaturated fatty acids have on cellular redox status.
Mitochondrial integrity is also critically influenced by cardiolpin, a phospholipid that is 
almost exclusively synthesised and located within the inner mitochondrial membrane (IMM) 
where it impacts on numerous mitochondrial processes, including cristae formation and reg-
ulating the spatial organisation of IMM proteins, such as those constituting the respiratory 
chain and those involved in synthesis and membrane exchange of ATP [58, 59]. Although the 
current study did not assay cardiolipin content in myotubes, there is evidence in the litera-
ture showing that chronic exposure of cells to PA results in cardiolipin loss [60]. This decline 
in cardiolipin is associated with reduced mitochondrial integrity as judged by depolarisation 
of the mitochondrial membrane and release of cytochrome c, which, notably, was not seen 
in cells incubated with OL or LO [60]. Significantly, cardiolipin is a tetra-acyl phospholipid in 
which the fatty acid chains are highly specific being comprised primarily of 18C unsaturated 
acyl chains (e.g. LO, 18:2) [58]. It is plausible that in cells chronically exposed to PA that car-
diolipin shifts away from the 18:2 rich species or, alternatively, is rendered more susceptible 
to peroxidation and degradation by ROS [61], whose generation would be greatly elevated 
in cells subject to PA oversupply. Since both OL and LO counter PA-induced increases in ROS 
as well as the associated disturbances in mitochondrial integrity and respiratory capacity 
it is plausible that these metabolic benefits may partly rely upon repressing mitochondrial 
cardiolipin loss by PA.
We, and others, have previously argued that sustained fuel overloading of muscle cells 
under circumstances when there is no associated increase in energy demand will ultimate-
ly culminate in mitochondrial insufficiency that will most likely exacerbate the effects of 
heightened ROS production and lipotoxicity on key cellular functions, such as those regu-
lated by insulin [21, 31, 62-64]. If this supposition is correct, then how is it that co-supple-
mentation of PO, OL or LO negates mitochondrial dysfunction induced by PA when there 
is unlikely to be any change in energy demand? One potential explanation might involve 
increased uncoupling across the IMM which would stimulate fuel oxidation without generat-
ing ATP [65]. Fatty acids have long been known to possess protonophoric activity and cause 
mild uncoupling by interacting with proteins that can transfer fatty acid anions across the 
IMM, such as ANT-1 [66, 67]. The presence of UCP3 may also contribute to uncoupling of 
OXPHOS in muscle cells, but this UCP family member may also function to remove fatty acid 
anions that have accumulated at the matrix-facing membrane [68]. Whilst only fatty acids 
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that have been activated to their acyl CoA derivatives are oxidised in the mitochondria, it has 
been suggested that in response to fatty acid over supply some fatty acyl CoA molecules are 
deactivated by mitochondrial thioesterase to help liberate CoA for use in other mitochon-
drial reactions [69]. This deactivation generates fatty acid anions that cannot be oxidised. 
Furthermore, under these circumstances, fatty acids that may not have been activated in the 
cytosol might “flip-flop” across the mitochondrial membrane and partition into the mito-
chondrial matrix where they can be deprotonated to their anion form. The fatty acid anions 
generated by these mechanisms are very susceptible to peroxidation and their accumulation 
in the matrix is potentially deleterious for mitochondrial function. Consequently, the export 
of fatty acid anions from the matrix via UCP3 will not only help sustain an optimal flux for 
fatty acid oxidation, but also help lower the membrane potential and limit ROS generation in 
myotubes [68]. The observation that the MUFAs and PUFA used in our study induce a partial 
depolarisation of the mitochondrial membrane and mitigate mitochondrial ROS production 
(Fig. 6) in PA-overloaded myotubes is fully consistent with this latter proposition. Our find-
ings also indicate that such changes, will themselves, be dependent upon these fatty acids 
restraining the PA-induced loss of proteins that critically support both mitochondrial form 
and function (e.g. MFN2, PGC1α, SDHA, NRF1, ANT1, UCP3 etc).
Conclusion
In summary, the present study provides evidence that saturated and unsaturated fatty 
acids exert distinct effects upon mitochondrial morphology and respiratory function in skel-
etal muscle cells in vitro. Specifically, our data indicate that unsaturated fatty acids confer 
protection against cellular inflammation, increased ROS generation and disturbances in mi-
tochondrial homeostasis induced by the sustained over supply of PA. Our data signal that 
such benefits are unlikely to be a consequence of simple uptake competition in which PA is 
excluded from muscle cells by unsaturated fatty acids given that we found that OL enhanced 
PA uptake in our hands. This observation is consistent with work showing that OL dose-
dependently increases oxidation of radio-labelled [14C]-palmitate to [14C]-CO2 in C2C12 myo-
tubes [70], which may be linked to the stimulatory effect that OL has on expression of genes 
involved in fatty acid oxidation in skeletal muscle both in vitro and in vivo [49]. Whether an 
increase in fatty acid oxidation alone can explain the observed increase in PA uptake that we 
see with OL or if this also involves upregulation cell surface fatty acid transporters is cur-
rently unknown, but testing these possibilities represent important investigative goals of 
future work. Whilst we remain mindful of the limitations of our in vitro cell based model we 
believe our data may have important implications for understanding the impact of dietary 
fat composition on cell/tissue function. Previous studies have, for example, pointed to the 
potential health and therapeutic benefits of unsaturated fatty acids in the treatment of meta-
bolic diseases such as diabetes [71] as well as cardiovascular [72] and neurodegenerative 
[73] conditions. Our observations would suggest that such benefits may be critically depend-
ent upon preserving cellular energy homeostasis and might be achievable in vivo if energy 
intake from dietary fat was weighted in favour of MUFAs and PUFAs, rather than SFAs. Future 
long-term dietary intervention studies comparing how modifying fat composition impacts 
upon inflammatory tone, metabolic profiles and energy status within tissues such as skeletal 
muscle may therefore prove extremely instructive in establishing the translational value of 
some of the findings reported here.
Abbreviations
ANT-1 (Adenine nucleotide translocase type 1); IKBα (Inhibitor of Nuclear factor Kappa-
B); IL-6 (Interleukin-6); LA (Laurate); LO (Linoleate); MFN2 (Mitofusin 2); MUFA (Monoun-
saturated Fatty Acid); NRF1 (Nuclear Respiratory Factor 1); NRF2 (Nuclear Factor Erythroid 
Cell Physiol Biochem 2020;54:975-993
DOI: 10.33594/000000282
Published online: 1 October 2020 990
Cellular Physiology 
and Biochemistry
© 2020 The Author(s). Published by 
Cell Physiol Biochem Press GmbH&Co. KG
Nisr et al.: Fatty Acids and Mitochondrial Function
2); OL (Oleate); PGC1α (Peroxisome proliferator-activated receptor gamma coactivator 1-al-
pha); PO (Palmitoleate); PUFA (Polyunsaturated Fatty Acid); ROS (Reactive Oxygen Species); 
SDHA (Succinate Dehydrogenase); SFA (Saturated Fatty Acid); SOD2 (Superoxide Dismutase 
2); ST (Stearate); UCP3 (Uncoupling protein 3).
Acknowledgements
We thank Calum Fordyce for participation in some of the experiments reported. We 
would like to thank members of Hundal laboratory for their comments on the manuscript.
All authors have read and approved the final manuscript submitted for publication.
Author Contributions
RBN performed the experiments, analysed the data and contributed to drafting and ed-
iting the manuscript. DSS performed experimental work. HSH directed the research, wrote 
and edited the manuscript.
Funding Sources
The studies reported herein were supported by Diabetes UK and the BBSRC.
Statement of Ethics
The authors have no ethical conflicts to disclose.
Disclosure Statement
The authors have no conflicts of interest to declare.
References
1 Boden G: Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver. Curr Diab Rep 
2006;6:177-181.
2 Green CJ, Pedersen M, Pedersen BK, Scheele C: Elevated NF-kappaB activation is conserved in human 
myocytes cultured from obese type 2 diabetic patients and attenuated by AMP-activated protein kinase. 
Diabetes 2011;60:2810-2819.
3 Boden G, Shulman GI: Free fatty acids in obesity and type 2 diabetes: defining their role in the development 
of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 2002;32:14-23.
4 Leyton J, Drury PJ, Crawford MA: Differential oxidation of saturated and unsaturated fatty acids in vivo in 
the rat. Br J Nutr 1987;57:383-393.
5 DeLany JP, Windhauser MM, Champagne CM, Bray GA: Differential oxidation of individual dietary fatty acids 
in humans. Am J Clin Nutr 2000;72:905-911.
6 Gaster M, Rustan AC, Beck-Nielsen H: Differential utilization of saturated palmitate and unsaturated oleate: 
evidence from cultured myotubes. Diabetes 2005;54:648-656.
7 Hariri N, Gougeon R, Thibault L: A highly saturated fat-rich diet is more obesogenic than diets with lower 
saturated fat content. Nutr Res 2010;30:632-643.
8 Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, et al.: Mitochondrial overload and 
incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 2008;7:45-56.
9 Green CJ, Macrae K, Fogarty S, Hardie DG, Sakamoto K, Hundal HS: Counter-modulation of fatty acid-
induced pro-inflammatory nuclear factor kappaB signalling in rat skeletal muscle cells by AMP-activated 
protein kinase. Biochem J 2011;435:463-474.
10 Coll T, Alvarez-Guardia D, Barroso E, Gomez-Foix AM, Palomer X, Laguna JC, et al.: Activation of peroxisome 
proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B 
activation and insulin resistance in skeletal muscle cells. Endocrinology 2010;151:1560-1569.
Cell Physiol Biochem 2020;54:975-993
DOI: 10.33594/000000282
Published online: 1 October 2020 991
Cellular Physiology 
and Biochemistry
© 2020 The Author(s). Published by 
Cell Physiol Biochem Press GmbH&Co. KG
Nisr et al.: Fatty Acids and Mitochondrial Function
11 Rutkowsky JM, Knotts TA, Ono-Moore KD, McCoin CS, Huang S, Schneider D, et al.: Acylcarnitines activate 
proinflammatory signaling pathways. Am J Physiol Endocrinol Metab 2014;306:E1378-E1387.
12 Powell DJ, Turban S, Gray A, Hajduch E, Hundal HS: Intracellular ceramide synthesis and protein kinase 
Czeta activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells. 
Biochem J 2004;382:619-629.
13 Chavez JA, Knotts TA, Wang LP, Li G, Dobrowsky RT, Florant GL, et al.: A role for ceramide, but not 
diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 
2003;278:10297-10303.
14 Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, et al.: Mechanism by which fatty acids inhibit insulin 
activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in 
muscle. J Biol Chem 2002;277:50230-50236.
15 Powell DJ, Hajduch E, Kular G, Hundal HS: Ceramide Disables 3-Phosphoinositide Binding to the Pleckstrin 
Homology Domain of Protein Kinase B (PKB)/Akt by a PKCzeta-Dependent Mechanism. Mol Cell Biol 
2003;23:7794-7808.
16 Ritov VB, Menshikova EV, He J, Ferrell RE, Goodpaster BH, Kelley DE: Deficiency of subsarcolemmal 
mitochondria in obesity and type 2 diabetes. Diabetes 2005;54:8-14.
17 Putti R, Migliaccio V, Sica R, Lionetti L: Skeletal Muscle Mitochondrial Bioenergetics and Morphology 
in High Fat Diet Induced Obesity and Insulin Resistance: Focus on Dietary Fat Source. Front Physiol 
2015;6:426.
18 Kelley DE, He J, Menshikova EV, Ritov VB: Dysfunction of mitochondria in human skeletal muscle in type 2 
diabetes. Diabetes 2002;51:2944-2950.
19 Holloszy JO: “Deficiency” of mitochondria in muscle does not cause insulin resistance. Diabetes 
2013;62:1036-1040.
20 Goodpaster BH: Mitochondrial deficiency is associated with insulin resistance. Diabetes 2013;62:1032-
1035.
21 Nisr RB, Shah DS, Ganley IG, Hundal HS: Proinflammatory NFkB signalling promotes mitochondrial 
dysfunction in skeletal muscle in response to cellular fuel overloading. Cell Mol Life Sci 2019;76:4887-
4904.
22 Yuzefovych LV, Solodushko VA, Wilson GL, Rachek LI: Protection from palmitate-induced mitochondrial 
DNA damage prevents from mitochondrial oxidative stress, mitochondrial dysfunction, apoptosis, and 
impaired insulin signaling in rat L6 skeletal muscle cells. Endocrinology 2012;153:92-100.
23 Dimopoulos N, Watson M, Sakamoto K, Hundal HS: Differential effects of palmitate and palmitoleate on 
insulin action and glucose utilization in rat L6 skeletal muscle cells. Biochem J 2006;399:473-481.
24 Cao H, Gerhold K, Mayers JR, Wiest MM, Watkins SM, Hotamisligil GS: Identification of a lipokine, a lipid 
hormone linking adipose tissue to systemic metabolism. Cell 2008;134:933-944.
25 Gillingham LG, Harris-Janz S, Jones PJ: Dietary monounsaturated fatty acids are protective against 
metabolic syndrome and cardiovascular disease risk factors. Lipids 2011;46:209-228.
26 Coll T, Eyre E, Rodriguez-Calvo R, Palomer X, Sanchez RM, Merlos M, et al.: Oleate reverses palmitate-
induced insulin resistance and inflammation in skeletal muscle cells. J Biol Chem 2008;283:11107-11116.
27 Peng G, Li L, Liu Y, Pu J, Zhang S, Yu J, et al.: Oleate blocks palmitate-induced abnormal lipid distribution, 
endoplasmic reticulum expansion and stress, and insulin resistance in skeletal muscle. Endocrinology 
2011;152:2206-2218.
28 Vessby B, Unsitupa M, Hermansen K, Riccardi G, Rivellese AA, Tapsell LC, et al.: Substituting dietary 
saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU 
Study. Diabetologia 2001;44:312-319.
29 Cruz MM, Lopes AB, Crisma AR, de Sa RCC, Kuwabara WMT, Curi R, et al.: Palmitoleic acid (16:1n7) 
increases oxygen consumption, fatty acid oxidation and ATP content in white adipocytes. Lipids Health Dis 
2018;17:55.
30 Staiger H, Staiger K, Haas C, Weisser M, Machicao F, Haring HU: Fatty acid-induced differential regulation 
of the genes encoding peroxisome proliferator-activated receptor-gamma coactivator-1alpha and -1beta in 
human skeletal muscle cells that have been differentiated in vitro. Diabetologia 2005;48:2115-2118.
31 Nisr RB, Affourtit C: Palmitate-induced changes in energy demand cause reallocation of ATP supply in rat 
and human skeletal muscle cells. Biochim Biophys Acta 2016;1857:1403–1411.
Cell Physiol Biochem 2020;54:975-993
DOI: 10.33594/000000282
Published online: 1 October 2020 992
Cellular Physiology 
and Biochemistry
© 2020 The Author(s). Published by 
Cell Physiol Biochem Press GmbH&Co. KG
Nisr et al.: Fatty Acids and Mitochondrial Function
32 Yuzefovych L, Wilson G, Rachek L: Different effects of oleate vs. palmitate on mitochondrial function, 
apoptosis, and insulin signaling in L6 skeletal muscle cells: role of oxidative stress. Am J Physiol Endocrinol 
Metab 2010;299:E1096-E1105.
33 Lee H, Lim JY, Choi SJ: Oleate Prevents Palmitate-Induced Atrophy via Modulation of Mitochondrial ROS 
Production in Skeletal Myotubes. Oxid Med Cell Longev 2017;2017:2739721.
34 Macrae K, Stretton C, Lipina C, Blachnio-Zabielska A, Baranowski M, Gorski J, et al.: Defining the role of 
DAG, mitochondrial function and lipid deposition in palmitate-induced proinflammatory signalling and its 
counter-modulation by palmitoleate. J Lipid Res 2013;54:2366-2378.
35 Cheon HG, Cho YS: Protection of palmitic acid-mediated lipotoxicity by arachidonic acid via channeling of 
palmitic acid into triglycerides in C2C12. J Biomed Sci 2014;21:13.
36 Cavaliere G, Trinchese G, Bergamo P, De Filippo C, Mattace Raso G, Gifuni G, et al.: Polyunsaturated Fatty 
Acids Attenuate Diet Induced Obesity and Insulin Resistance, Modulating Mitochondrial Respiratory 
Uncoupling in Rat Skeletal Muscle. PLoS One 2016;11:e0149033.
37 Hajduch E, Alessi DR, Hemmings BA, Hundal HS: Constitutive activation of Protein Kinase Ba (PKBa) by 
membrane targeting promotes glucose and System A amino acid transport, protein synthesis and GSK3 
inactivation in L6 muscle cells. Diabetes 1998;47:1006-1013.
38 Stierwalt HD, Ehrlicher SE, Bergman BC, Robinson MM, Newsom SA: Insulin-stimulated Rac1-GTP binding 
is not impaired by palmitate treatment in L6 myotubes. Physiol Rep 2018;6:e13956.
39 Yoon JH, Kim D, Jang JH, Ghim J, Park S, Song P, et al.: Proteomic analysis of the palmitate-induced myotube 
secretome reveals involvement of the annexin A1-formyl peptide receptor 2 (FPR2) pathway in insulin 
resistance. Mol Cell Proteomics 2015;14:882-892.
40 Iqbal S, Ostojic O, Singh K, Joseph AM, Hood DA: Expression of mitochondrial fission and fusion regulatory 
proteins in skeletal muscle during chronic use and disuse. Muscle Nerve 2013;48:963-970.
41 Senn JJ: Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in 
myotubes. J Biol Chem 2006;281:26865-26875.
42 de Alvaro C, Teruel T, Hernandez R, Lorenzo M: Tumor necrosis factor alpha produces insulin resistance 
in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner. J Biol Chem 
2004;279:17070-17078.
43 Alvarez-Guardia D, Palomer X, Coll T, Serrano L, Rodriguez-Calvo R, Davidson MM, et al.: PPARbeta/delta 
activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells. Biochim 
Biophys Acta 2011;1811:59-67.
44 Zhang C, Jiang H, Wang P, Liu H, Sun X: Transcription factor NF-kappa B represses ANT1 transcription and 
leads to mitochondrial dysfunctions. Sci Rep 2017;7:44708.
45 Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, et al.: Mechanisms controlling 
mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999;98:115-
124.
46 Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al.: PGC-1alpha-responsive 
genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 
2003;34:267-273.
47 Lopez-Bernardo E, Anedda A, Sanchez-Perez P, Acosta-Iborra B, Cadenas S: 4-Hydroxynonenal induces 
Nrf2-mediated UCP3 upregulation in mouse cardiomyocytes. Free Radic Biol Med 2015;88:427-438.
48 Au HC, Scheffler IE: Promoter analysis of the human succinate dehydrogenase iron-protein gene--both 
nuclear respiratory factors NRF-1 and NRF-2 are required. Eur J Biochem 1998;251:164-174.
49 Lim JH, Gerhart-Hines Z, Dominy JE, Lee Y, Kim S, Tabata M, et al.: Oleic acid stimulates complete oxidation 
of fatty acids through protein kinase A-dependent activation of SIRT1-PGC1alpha complex. J Biol Chem 
2013;288:7117-7126.
50 Mancini G, Pirruccio K, Yang X, Bluher M, Rodeheffer M, Horvath TL: Mitofusin 2 in Mature Adipocytes 
Controls Adiposity and Body Weight. Cell Rep 2019;27:648.
51 Zorzano A, Hernández-Alvarez MI, Sebastián D, Muñoz JP: Mitofusin 2 as a driver that controls energy 
metabolism and insulin signaling. Antioxid Redox Signal 2015;22:1020-1031.
52 Soriano FX, Liesa M, Bach D, Chan DC, Palacin M, Zorzano A: Evidence for a mitochondrial regulatory 
pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-
related receptor-alpha, and mitofusin 2. Diabetes 2006;55:1783-1791.
Cell Physiol Biochem 2020;54:975-993
DOI: 10.33594/000000282
Published online: 1 October 2020 993
Cellular Physiology 
and Biochemistry
© 2020 The Author(s). Published by 
Cell Physiol Biochem Press GmbH&Co. KG
Nisr et al.: Fatty Acids and Mitochondrial Function
53 Jheng HF, Tsai PJ, Guo SM, Kuo LH, Chang CS, Su IJ, et al.: Mitochondrial fission contributes to mitochondrial 
dysfunction and insulin resistance in skeletal muscle. Mol Cell Biol 2012;32:309-319.
54 Wu S, Zhou F, Zhang Z, Xing D: Mitochondrial oxidative stress causes mitochondrial fragmentation via 
differential modulation of mitochondrial fission-fusion proteins. FEBS J 2011;278:941-954.
55 Ahmed SMU, Luo L, Namani A, Wang XJ, Tang X: Nrf2 signaling pathway: Pivotal roles in inflammation. 
Biochim Biophys Acta Mol Basis Dis 2017;1863:585-597.
56 Nguyen T, Nioi P, Pickett CB: The Nrf2-antioxidant response element signaling pathway and its activation by 
oxidative stress. J Biol Chem 2009;284:13291-13295.
57 Tebay LE, Robertson H, Durant ST, Vitale SR, Penning TM, Dinkova-Kostova AT, et al.: Mechanisms of 
activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the 
pathways through which it attenuates degenerative disease. Free Radic Biol Med 2015;88:108-146.
58 Chicco AJ, Sparagna GC: Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am J 
Physiol Cell Physiol 2007;292:C33-C44.
59 Ban T, Ishihara T, Kohno H, Saita S, Ichimura A, Maenaka K, et al.: Molecular basis of selective mitochondrial 
fusion by heterotypic action between OPA1 and cardiolipin. Nat Cell Biol 2017;19:856-863.
60 Buratta M, Castigli E, Sciaccaluga M, Pellegrino RM, Spinozzi F, Roberti R, et al.: Loss of cardiolipin in 
palmitate-treated GL15 glioblastoma cells favors cytochrome c release from mitochondria leading to 
apoptosis. J Neurochem 2008;105:1019-1031.
61 Wiswedel I, Gardemann A, Storch A, Peter D, Schild L: Degradation of phospholipids by oxidative stress--
exceptional significance of cardiolipin. Free Radic Res 2010;44:135-145.
62 Heilbronn LK, Gan SK, Turner N, Campbell LV, Chisholm DJ: Markers of mitochondrial biogenesis and 
metabolism are lower in overweight and obese insulin-resistant subjects. J Clin Endocrinol Metab 
2007;92:1467-1473.
63 Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI: Impaired mitochondrial activity in the insulin-
resistant offspring of patients with type 2 diabetes. N Engl J Med 2004;350:664-671.
64 Lipina C, Macrae K, Suhm T, Weigert C, Blachnio-Zabielska A, Baranowski M, et al.: Mitochondrial Substrate 
Availability and its Role in Lipid-Induced Insulin Resistance and Proinflammatory Signalling in Skeletal 
Muscle. Diabetes 2013;62:3426-3436.
65 Harper JA, Dickinson K, Brand MD: Mitochondrial uncoupling as a target for drug development for the 
treatment of obesity. Obes Rev 2001;2:255-265.
66 Skulachev VP: Fatty acid circuit as a physiological mechanism of uncoupling of oxidative phosphorylation. 
FEBS Lett 1991;294:158-162.
67 Sparks LM, Gemmink A, Phielix E, Bosma M, Schaart G, Moonen-Kornips E, et al.: ANT1-mediated fatty acid-
induced uncoupling as a target for improving myocellular insulin sensitivity. Diabetologia 2016;59:1030-
1039.
68 Schrauwen P, Hesselink MK: The role of uncoupling protein 3 in fatty acid metabolism: protection against 
lipotoxicity? Proc Nutr Soc 2004;63:287-292.
69 Himms-Hagen J, Harper ME: Physiological role of UCP3 may be export of fatty acids from mitochondria 
when fatty acid oxidation predominates: an hypothesis. Exp Biol Med (Maywood) 2001;226:78-84.
70 Capel F, Cheraiti N, Acquaviva C, Henique C, Bertrand-Michel J, Vianey-Saban C, et al.: Oleate dose-
dependently regulates palmitate metabolism and insulin signaling in C2C12 myotubes. Biochim Biophys 
Acta 2016;1861:2000-2010.
71 Palomer X, Pizarro-Delgado J, Barroso E, Vazquez-Carrera M: Palmitic and Oleic Acid: The Yin and Yang of 
Fatty Acids in Type 2 Diabetes Mellitus. Trends Endocrinol Metab 2018;29:178-190.
72 Kris-Etherton PM, Petersen KF, Van Horn L: Convincing evidence supports reducing saturated fat to 
decrease cardiovascular disease risk. BMJ Nutrition, Prevention & Health 2018;1:23-26.
73 de Lau LM, Bornebroek M, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM: Dietary fatty acids and the 
risk of Parkinson disease: the Rotterdam study. Neurology 2005;64:2040-2045.
